Research Article

Lack of Efficacy of Combined Carbohydrate Antigen Markers for Lung Cancer Diagnosis

Table 3

Compare the four panels of biomarkers in lung cancer diagnosis.

PanelsSensitivity ( value)Specificity ( value)PPV ( value)NPV ( value)AUC ( value)

Panel 1 vs. panel 20.0630.5070.8700.1260.194 ()
Panel 1 vs. panel 3<0.00010.0730.988<0.00010.039 ()
Panel 1 vs. panel 40.0630.1480.5190.1800.10 ()
Panel 2 vs. panel 3<0.0010.0150.871<0.0001<0.0001 ()
Panel 2 vs. panel 41.0000.4320.6250.8780.387 ()
Panel 3 vs. panel 4<0.0010.0010.557<0.0001<0.0001 ()

Panel = CYFR21, CEA, NSE, and SCC; panel 2 = CYFR21, CEA, NSE, SCC, CA125, and CA15-3; panel 3 = CA125, CA15-3, CA19-9, CA50, CA242, and CA724; panel 4 = CYFR21, CEA, NSE, SCC, CA125, CA15-3, CA19-9, CA50, CA242, and CA724.